Cary Street Partners Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-16,840	Closed	-$17K	–	155
2021 Q1	$17K	Sell	16,840 -11,695	-41%	-$11.8K	﹤0.01%	177
2020 Q4	$642K	Buy	+28,535	New	+$642K	0.19%	106